CleaRecon DL, a technology for improving cone-beam computed tomography image quality, is now available in the US and Europe.

Intalight's DREAM OCT leverages ultra-wide swept-source technology to cater to the needs of retina specialists.

After free agency and the NFL draft, the safety position for the Indianapolis Colts is still looking a bit thin. While the addition of Cam Bynum in free agency will greatly improve the level of play ...

Addressing supporters on election night, Poilievre congratulated Liberal leader and incumbent Prime Minister Mark Carney for their "razor thin" win. While speaking to supporters, the conservative ...

Basel: Roche has announced the introduction of its Chest Pain Triage algorithm as part of the navify Algorithm Suite. Developed in collaboration with Universitätsklinikum Heidelberg, this new ...

The King and Queen will be joined by the Prince and Princess of Wales as they lead the nation in marking the 80th anniversary of VE Day. From a Buckingham Palace balcony fly-past to hosting a tea ...

Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for percutaneous vessel closure. Vivasure’s device is designed ...

Roche, in collaboration with Universitätsklinikum Heidelberg, has developed a Chest Pain Triage algorithm - a CE-marked IVD medical device 1 set to transform cardiac care This novel algorithm ...

Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...

Large-bore access is required for a range of cardiovascular interventions such as transcatheter aortic valve replacement (TAVR). Image credit: Shutterstock/MAD ...

We look forward to utilizing this technology to treat our patients." "Securing CE Mark approval for PerQseal Elite marks a major milestone for Vivasure and for patients undergoing complex ...

Optune Lua is now approved for use concurrently with immune checkpoint inhibitors or docetaxel in adult patients with metastatic NSCLC who have progressed on or after a platinum-based regimen CE ...